Effect of TNF antagonists on the T-lymphocyte response

Joint Bone Spine

Volumn 74, Issue 6, 2007, Pages 558-559

  Emilie, Dominique ^a  

^a INSERM   (France)

Author keywords

Monoclonal antibody; T lymphocyte; TNF; TNF antagonist; Tuberculosis

Indexed keywords

ADALIMUMAB; ETANERCEPT; GAMMA INTERFERON; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CYTOKINE PRODUCTION; DRUG EFFECT; EX VIVO STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; SHORT SURVEY; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; CELLS, CULTURED; HUMANS; IMMUNOGLOBULIN G; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37049034695     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.07.003     Document Type: Short Survey

References (8)

1. Zou J., Rudwaleit M., Brandt J., Thiel A., Braun J., and Sieper J. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab. Arthritis Rheum 48 (2003) 780-790
2. Vigna-Perez M., Abud-Mendoza C., Portillo-Salazar H., Alvarado-Sanchez B., Cuevas-Orta E., Moreno-Valdes R., et al. Immune effects of therapy with adalimumab in patients with rheumatoid arthritis. Clin Exp Immunol 141 (2005) 372-380
3. Catrina A.I., Trollmo C., af Klint E., Engstrom M., Lampa J., Hermansson Y., et al. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Arthritis Rheum 52 (2005) 61-72
4. Berg L., Lampa J., Rogberg S., van Vollenhoven R., and Klareskog L. Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors. Ann Rheum Dis 60 (2001) 133-139
5. Hamdi H., Mariette X., Godot V., Weldingh K., Hamid A.M., Prejean M.V., et al. Inhibition of anti-tuberculosis T-lymphocyte function with tumor necrosis factor antagonists. Arthritis Res Thera 8 (2006) R114
6. Devergne O., Marfaing-Koka A., Schall T., Leger-Ravet M.B., Sadick M.M., Peuchmaur M., et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 179 (1994) 1689-1694
7. Marfaing-Koka A., Maravic M., Humbert M., Galanaud P., and Emilie D. Contrasting effects of interleukin-4, interleukin-10 and corticosteroids on RANTES production by human monocytes. Int Immunol 10 (1996) 1587-1594
8. Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T.J., Galanaud P., et al. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol 154 (1995) 1870-1878